SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-07 |
| Reported value | $798,650,757 |
| Positions | 15 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| PROTAGONIST THERAPEUTICS INC | PTGX | COM | $300,220,852 | 2,449,183 |
| NANOBIOTIX | NBTX | SPONSORED ADS | $212,017,863 | 5,623,816 |
| MEIRAGTX HLDGS PLC | MGTX | COM | $89,720,775 | 6,641,064 |
| RAPPORT THERAPEUTICS INC | RAPP | COM | $74,360,823 | 1,784,517 |
| CONTINEUM THERAPEUTICS INC | CTNM | CL A | $32,438,645 | 1,979,173 |
| LEGEND BIOTECH CORP | LEGN | SPONSORED ADS | $23,525,244 | 814,586 |
| CVRX INC | CVRX | COM | $20,687,786 | 4,024,861 |
| XENCOR INC | XNCR | COM | $12,043,798 | 748,062 |
| CEREBRAS SYSTEMS INC | CBRS | COM CL A | $11,842,506 | 53,586 |
| FATE THERAPEUTICS INC | FATE | COM | $9,123,473 | 3,379,064 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.